CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics.

Synopsis

CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics, a medtech firm, with participation from China Life, Qianhai FOF, C&D, JD Invesment, Jingming Capital, Lucion, Source Code Capital, Cedarlake Capital and Riverhead Capital.

Principals

target

SIBIONICS

bidder

Source Code Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

yu zhao

Chairman at SIBIONICS

Manager

target

Deal

£ 93 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy